NASDAQ
No price data available for this timeframe.
Beam Therapeutics Inc. (BEAM) has a revenue compound annual growth rate of 466.27% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.